The dominant negative thyroid hormone receptor β-mutant Δ337T alters PPARα signaling in heart

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 2, 2007, Pages

  Buroker, Norman E ^a   Young, Martin E ^b   Wei, Caimiao ^c   Serikawa, Kyle ^d   Ge, Ming ^a   Ning, Xue Han ^a   Portman, Michael A ^a,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac metabolism; Microarrays; Nuclear receptors

Indexed keywords

CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIRINIXIC ACID; PROTEIN; PROTEIN MTE 1; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; HEART; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; WILD TYPE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ION CHANNELS; MICE; MICE, TRANSGENIC; MITOCHONDRIAL PROTEINS; MUTANT PROTEINS; MYOCARDIUM; PPAR ALPHA; PYRIMIDINES; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; THYROID HORMONE RECEPTORS BETA;

EID: 33846873689     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00267.2006     Document Type: Article

References (34)

1. Abel ED, Kaulbach HC, Campos-Barros A, Ahima RS, Boers ME, Hashimoto K, Forrest D, Wondisford FE. Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin. J Clin Invest 103: 271-279, 1999.
2. Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, Baxter JD. Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl 25: S2-S11, 1998.
3. Araki O, Ying H, Furuya F, Zhu X, Cheng SY. Thyroid hormone receptor beta mutants: dominant negative regulators of peroxisome proliferator-activated receptor gamma action. Proc Natl Acad Sci USA 102: 16251-16256, 2005.
4. Beato M, Klug J. Steroid hormone receptors: an update. Human Reprod Updat 6: 225-236, 2000.
5. Bogazzi F, Hudson LD, Nikodem VM. A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor. J Biol Chem 269: 11683-11686, 1994.
6. Chu R, Madison LD, Lin Y, Kopp P, Rao MS, Jameson JL, Reddy JK. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci USA 92: 11593-11597, 1995.
7. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 12: 447-452, 2002.
8. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
9. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 14: 85-90, 2003.
10. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, Cohen RN, Wondisford FE. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98: 3998-4003, 2001.
11. Hashimoto T, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem 281: 295-302, 2006.
12. Hunter J, Kassam A, Winrow CJ, Rachubinski RA, Capone JP. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol Cell Endocrinol 116: 213-221, 1996.
13. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Matsuda M, Yamaguchi I. Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol Heart Circ Physiol 286: H1696-H1705, 2004.
14. Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res 89: 153-159, 2001.
15. Kinugawa K, Long CS, Bristow MR. Expression of TR isoforms in failing human heart. J Clin Endocrinol Metab 86: 5089-5090, 2001.
16. 13C isotopomer analysis. Am J Physiol Endocrinol Metab 281: E983-E990, 2001.
17. Liang F, Wang F, Zhang S, Gardner DG. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes. Endocrinology 144: 4187-4194, 2003.
18. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
19. McClure TD, Young ME, Taegtmeyer H, Ning XH, Buroker NE, Lopez-Guisa J, Portman MA. Thyroid hormone interacts with PPARα and PGC-1 during mitochondrial maturation in sheep heart. Am J Physiol Heart Circ Physiol 289: H2258-H2264, 2005.
20. Miyamoto T, Kaneko A, Kakizawa T, Yajima H, Kamijo K, Sekine R, Hiramatsu K, Nishii Y, Hashimoto T, Hashizume K. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. Competitive binding to the response element. J Biol Chem 272: 7752-7758, 1997.
21. Murray AJ, Panagia M, Hauton D, Gibbons GF, Clarke K. Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. Diabetes 54: 3496-3502, 2005.
22. Nemoto S, DeFreitas G, Mann DL, Carabello BA. Effects of changes in left ventricular contractility on indexes of contractility in mice. Am J Physiol Heart Circ Physiol 283: H2504-H2510, 2002.
23. Ortiga-Carvalho TM, Hashimoto K, Pazos-Moura CC, Geenen D, Cohen R, Lang RM, Wondisford FE. Thyroid hormone resistance in the heart: role of the thyroid hormone receptor beta isoform. Endocrinology 145: 1625-1633, 2004.
24. Pazos-Moura C, Abel ED, Boers ME, Moura E, Hampton TG, Wang J, Morgan JP, Wondisford FE. Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor. Circ Res 86: 700-706, 2000.
25. Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Dieguez C, Gualillo O, Gonzalez-Juanatey JR, Lago F. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 579: 5163-5169, 2005.
26. 3 on phosphorylation potential in the sheep heart in vivo. Am J Physiol Heart Circ Physiol 288: H2484-H2490, 2005.
27. Ripoli A, Pingitore A, Favilli B, Bottoni A, Turchi S, Osman NF, De Marchi D, Lombardi M, L'Abbate A, Iervasi G. Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 45: 439-445, 2005.
28. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165: 2460-2466, 2005.
29. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, Castano JP, Malagon MM. Regulation of pituitary cell function by adiponectin. Endocrinology 2006 Oct 12 [Epub ahead of print].
30. Schiffrin EL. Peroxisome proliferator-activated receptors and cardiovascular remodeling. Am J Physiol Heart Circ Physiol 288: H1037-H1043, 2005.
31. Stavinoha MA, RaySpellicy JW, Essop MF, Graveleau C, Abel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, Young ME. Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-α-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab 287: E888-E895, 2004.
32. Stavinoha MA, Rayspellicy JW, Hart-Sailors ML, Mersmann HJ, Bray MS, Young ME. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. Am J Physiol Endocrinol Metab 287: E878-E887, 2004.
33. Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, Rojas-Caro S, Madore S, Wahli W, Tafuri S, Muller M, Kersten S. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 392: 313-324, 2005.
34. Zhang J, Lazar MA. The mechanism of action thyroid hormones. Annu Rev Physiol 62: 439-466, 2000.